Gadolinium-based contrast agents (GBCAs) used for MRI are known to cause gadolinium depositions in the brain. In this study we show that the using quantitative MRI we can detect gadolinium depositions after fewer doses of GBCAs than generally seen on conventional MRI. We included 43 patients that were earlier enrolled in a prospective longitudinal cohort study of early Multiple Sclerosis. All patients had received the linear GBCA Magnevist. Measurements of the longitudinal relaxation rate R1 showed a significant increase in dentate nuclei, globi pallidi and frontal grey matter.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords